Genixus is a pharmaceutical company that elevates acute and critical care medicines.
Genixus has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.
Genixus is headquartered in Kannapolis, United States.
Genixus is a pharmaceutical company that elevates acute and critical care medicines.
Genixus is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genixus — Funding & Investors." VCBacked, January 18, 2022, https://www.vcbacked.co/company/genixus. Accessed August 16, 2026.
VCBacked. (2022). Genixus — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/genixus
{{cite web |title=Genixus — Funding & Investors |url=https://www.vcbacked.co/company/genixus |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated